Customized approach.

24 April 2017

Crossing the chasm: Lessons learned in transitioning to the SaaS business model

Software companies of all shapes and sizes should ask themselves if they are in the right position to compete in a SaaS-driven environment.

10 March 2017

Digital deals: Spotlight on life sciences

Inorganic strategies are driving the digital agenda in life sciences.

1 March 2017

Video: Outlook for the medtech sector

Watch Parthenon-EY Managing Director and Co-head of Health Care Dan Shoenholz and EY Partner Arda Ural discuss growth themes in medtech in 2017.

1 February 2017

Investing in the pet industry

Managing Director Liz Lippert and Managing Director and Co-head of Private Equity Andres Saenz discuss opportunities in the pet industry for PE investors.

24 January 2017

If you look at your company the way an activist does, what would you change?

Parthenon-EY’s in-depth research shows where and how companies can harness shareholder activists’ tactics for competitive advantage.

4 January 2017

The new innovation imperative: Reshaping biopharma business models

New technologies, customers and competition are forcing — and enabling — biopharmaceutical companies to find novel ways to create and capture value.

About us

The Parthenon-EY team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.

Featured events

Our people